MiR-27a promotes EMT in ovarian cancer through active Wnt/ 𝜷-catenin signalling by targeting FOXO1.

CONCLUSIONS: Taken together, these results indicate that targeting miR-27a and FOXO1 could represent a strategy for anticancer therapy in ovarian cancer.
PMID: 30614794 [PubMed - as supplied by publisher]

Source: Cancer Biomarkers - January 8, 2019 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research